Table 6. CD4 T-lymphocyte counts (basic model M1), HIV VL (M6 model), and HAART (M7 model) effects on HPV clearance probability, HPV type-specific, in HIV-1-positive adolescent females, REACH cohort.
HPV type | M1 (basic model): CD4 effect | M6 model:HIV VL effect, | M7 model: HAART(PI) effect | ||
u11 (SE) | β11 (SE)a | ||||
HPV16/16-like group | HPV16 | −1.72(0.33)** | 1.78(0.56)** | ns | 0.99(0.38)** |
HPV31 | −1.55(0.32)** | 0.97(0.55)* | −0.14(0.17) | 0.01(0.34) | |
HPV52 | −1.42(0.31)** | 1.28(0.56)** | −0.25(0.2) | 0.38(0.38) | |
HPV58 | −1.54(0.28)** | 0.82(0.48)* | −0.53(0.22)** | 0.001(0.39) | |
HPV67 | nsb | ns | −8.46(8.3) | 0.65(1.16) | |
HPV16/16-like | −1.52(0.15)** | 1.15(0.27)** | −0.17(0.09)* | 0.33(0.18)* | |
HPV18/18-like group | HPV18 | −2.1(0.42)** | 2.97(0.89)** | −0.37(0.28), p = 0.188 | 0.56(0.47) |
HPV39 | −0.78(0.58) | 1.97(1.24) | ns | 0.06(0.75) | |
HPV45 | −1.66(0.5)** | 3.03(1.13)** | 0.03(0.24) | −0.26(0.57) | |
HPV51 | −1.41(0.53)** | 1.61(1.05) | 0.62(0.39)* | −0.15(0.71) | |
HPV59 | −1.12(0.31)** | 0.86(0.56)* | −0.43(0.2)** | 0.62(0.36)* | |
HPV26 | −0.49(0.51) | 0.87(1.10) | −0.08(0.4) | 0.22(0.65) | |
HPV18/18-like | −1.29(0.18)** | 1.58(0.36)** | −0.14(0.12) | ns |
Note: * 0.05≤p<0.1; ** p<0.05. u00, β00, u11, and β11 are related to the parameters in equation (2).
– the units of β00 and β11 are 1000/[C], where [C] are the units of CD4 cell counts, i.e., cells/mm3.; b – non-significant.
SEs were obtained by re-estimating the model in which probability at specific value of CD4 cell count was chosen as a model parameter instead of .